Neda A. Moatamed, MD

Neda A. Moatamed, MD

Cytopathology| Pathology
Primary Location
Fine Needle Biopsy Clinic
Medical Plaza 100
245
Los Angeles, California 90095
Phone
Fax
310-983-3289

About

Academic Title: Clinical Professor of Pathology and Laboratory Medicine

Department Title: Chief of Gynecology Pathology and Director of Fine Needle Aspiration Clinic

Specialties: Surgical Pathology, Cytopathology, Breast Pathology, Gynecologic Pathology

Education

Medical Board Certifications

Cytopathology, American Board of Pathology, 2005
Pathology-Anatomic/Pathology-Clinical, American Board of Pathology, 2004

Fellowships

UCLA School of Medicine, 2006
LAC + USC Medical Center, 2005
LAC + USC Medical Center, 2004

Residency

LAC + USC Medical Center, 2003

Degree

University of Medical Sciences of Iran, MD, 1996

Hospital Affiliations

Ronald Reagan UCLA Medical Center

Research

Publications

  1. Conrad R, Yang SE, Chang S, Bhasin M, Sullivan PS, Moatamed NA, Lu DY. Comparison of CytopathologistPerformed Ultrasound-Guided Fine-Needle Aspiration With Cytopathologist-Performed Palpation-Guided FineNeedle Aspiration: A Single Institutional Experience. Arch Pathol Lab Med. 2018.
  2. Kassardjian A, Shintaku PI, Moatamed NA. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas. PLoS One. 2018;13(4):e0195958.
  3. Moatamed NA, DeNicola M, Nham P, Phan RT. Rare occurrence of EGFR exon 19 deletion in invasive lobular carcinoma of the breast. Breast J. 2018;24(3):429-31.
  4. Reddy OL, Shintaku PI, Moatamed NA. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas. Diagn Pathol. 2017;12(1):45.
  5. Yang SE, Sullivan PS, Zhang J, Govind R, Levin MR, Rao JY, Moatamed NA. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology? Cancer Cytopathol. 2016;124(2):100-9.
  6. Woo JS, Apple SK, Sullivan PS, Rao JY, Ostrzega N, Moatamed NA. Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. Diagn Pathol. 2016;11(1):102.
  7. Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES. Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-kappaB. Mol Cell Biol. 2016;36(12):1776-92.
  8. Khanlou N, Shintaku P, Yi J, Moatamed NA. Evaluation of PAX8 Expression in Brain Tissue and Related Neoplasms. Appl Immunohistochem Mol Morphol. 2016;24(3):207-9.
  9. Scafoglio C, Hirayama BA, Kepe V, Liu J, Ghezzi C, Satyamurthy N, Moatamed NA, Huang J, Koepsell H, Barrio JR, Wright EM. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015;112(30):E4111-9.
  10. Moatamed NA, Wu A, Sarah K, Apple SK. Cytokeratin 7 negative invasive breast carcinoma: clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up. J Clin Pathol. 2015;68(6):484-7.